Advertisement

European Radiology

, Volume 26, Issue 9, pp 3310–3318 | Cite as

Contrast-induced nephropathy in CT: incidence, risk factors and strategies for prevention

  • Shu Min Tao
  • Julian L. Wichmann
  • U. Joseph Schoepf
  • Stephen R. Fuller
  • Guang Ming Lu
  • Long Jiang ZhangEmail author
Contrast Media

Abstract

In the past, a high percentage of hospital-acquired renal failure was attributed to contrast media. That position is now very controversial. Recently, doubts have been raised regarding the real relationship between acute kidney injury and intravenous contrast media administration. Similarly, statements about specific methods of preventing contrast-inducing nephropathy have been challenged. This review article addresses the controversies of incidence, causation, and prevention in an attempt to help the practicing radiologist adopt methods for their own department.

Key Points

The reported CIN incidence ranges from 2–12 % following contrast-enhanced CT.

Studies without a non-contrast CT control group may overestimate CIN incidence.

Development and application of a comprehensive CIN prevention strategy is recommended.

Keywords

Acute kidney injury Contrast-induced nephropathy Computed tomography Contrast media Prevention strategy 

Notes

Acknowledgments

The scientific guarantor of this publication is Long Jiang Zhang. The authors of this manuscript declare relationships with the following companies: UJS is a consultant for and receives research support from Bayer, Bracco, GE, Medrad, and Siemens. The other authors have no conflicts of interest to declare.

This study has received funding from the Program for New Century Excellent Talents in University (NCET-12-0260 to LJZ). No complex statistical methods were necessary for this paper. Institutional review board approval was not obtained because this is a review paper. Written informed consent was not obtained because this is a review paper. No study subjects or cohorts have been previously reported. Methodology: performed at one institution.

References

  1. 1.
    Bartels ED, Brun GC, Gammeltoft A et al (1954) Acute anuria following intravenous pyelography in a patient with myelomatosis. Acta Med Scand 150:297–302CrossRefPubMedGoogle Scholar
  2. 2.
    Haveman JW, Gansevoort RT, Bongaerts AH et al (2006) Low incidence of nephropathy in surgical ICU patients receiving intravenous contrast: a retrospective analysis. Intensive Care Med 32:1199–1205CrossRefPubMedGoogle Scholar
  3. 3.
    Deek H, Newton P, Sheerin N et al (2014) Contrast media induced nephropathy: a literature review of the available evidence and recommendations for practice. Aust Crit Care 27:166–171CrossRefPubMedGoogle Scholar
  4. 4.
    Chertow GM, Burdick E, Honour M et al (2005) Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16:3365–3370CrossRefPubMedGoogle Scholar
  5. 5.
    Kooiman J, Pasha SM, Zondag W et al (2012) Meta-analysis: serum creatinine changes following contrast enhanced CT imaging. Eur J Radiol 81:2554–2561CrossRefPubMedGoogle Scholar
  6. 6.
    Mitchell AM, Jones AE, Tumlin JA et al (2012) Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting. Clin J Am Soc Nephrol 5:4–9CrossRefGoogle Scholar
  7. 7.
    Lee J, Cho JY, Lee HJ et al (2014) Contrast-induced nephropathy in patients undergoing intravenous contrast-enhanced computed tomography in Korea: a multi-institutional study in 101487 patients. Korean J Radiol 15:456–463CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Davenport MS, Khalatbari S, Cohan RH et al (2013) Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate. Radiology 268:719–728CrossRefPubMedGoogle Scholar
  9. 9.
    Kooiman J, Sijpkens YW, van Buren M et al (2014) Randomised trial of no hydration vs. sodium bicarbonate hydration in patients with chronic kidney disease undergoing acute computed tomography-pulmonary angiography. J Thromb Haemost 12:1658–1666CrossRefPubMedGoogle Scholar
  10. 10.
    Andreucci M, Solomon R, Tasanarong A (2014) Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention. Biomed Res Int. 741018Google Scholar
  11. 11.
    Lima FO, Lev MH, Levy RA et al (2010) Functional contrast-enhanced CT for evaluation of acute ischemic stroke does not increase the risk of contrast-induced nephropathy. AJNR Am J Neuroradiol 31:817–821CrossRefPubMedGoogle Scholar
  12. 12.
    McGillicuddy EA, Schuster KM, Kaplan LJ et al (2010) Contrast-induced nephropathy in elderly trauma patients. J Trauma 68:294–297CrossRefPubMedGoogle Scholar
  13. 13.
    Kuhn MJ, Chen N, Sahani DV et al (2008) The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure. AJR Am J Roentgenol 191:151–157CrossRefPubMedGoogle Scholar
  14. 14.
    Stacul F, van der Molen AJ, Reimer P et al (2011) Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 21:2527–2541CrossRefPubMedGoogle Scholar
  15. 15.
    McDonald JS, McDonald RJ, Carter RE et al (2014) Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate. Radiology 271:65–73CrossRefPubMedGoogle Scholar
  16. 16.
    McDonald RJ, McDonald JS, Carter RE et al (2014) Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality. Radiology 273:714–725CrossRefPubMedGoogle Scholar
  17. 17.
    Morcos SK, Thomsen HS, Webb JA (1999) Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 8:1602–1613CrossRefGoogle Scholar
  18. 18.
    Contrast media safety committee (2013) ESUR guidelines on contrast media version 8.1. 2013. http://www.esur.org/guidelines/
  19. 19.
    Mehta RL, Kellum JA, Shah SV et al (2007) Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2:R31CrossRefGoogle Scholar
  20. 20.
    Ohno I, Hayashi H, Aonuma K et al (2013) Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version: JSN, JRS, and JCS Joint Working Group. Clin Exp Nephrol 17:441–479CrossRefPubMedGoogle Scholar
  21. 21.
    Sendeski MM (2011) Pathophysiology of renal tissue damage by iodinated contrast media. Clin Exp Pharmacol Physiol 38:292–299CrossRefPubMedGoogle Scholar
  22. 22.
    Nazıroğlu M, Yoldaş N, Uzgur EN et al (2013) Role of contrast media on oxidative stress, Ca(2+) signaling and apoptosis in kidney. J Membr Biol 246:91–100CrossRefPubMedGoogle Scholar
  23. 23.
    Sadat U (2013) Radiographic contrast-media-induced acute kidney injury: pathophysiology and prophylactic strategies. ISRN Radiol 496438Google Scholar
  24. 24.
    Chang CF, Lin CC (2013) Current concepts of contrast-induced nephropathy: a brief review. J Chin Med Assoc 76:673–681CrossRefPubMedGoogle Scholar
  25. 25.
    Zhang Y, Wang J, Yang X et al (2012) The serial effect of iodinated contrast media on renal hemodynamics and oxygenation as evaluated by ASL and BOLD MRI. Contrast Media Mol Imaging 7:418–425CrossRefPubMedGoogle Scholar
  26. 26.
    Cronin RE (2010) Contrast-induced nephropathy: pathogenesis and prevention. Pediatr Nephrol 25:191–204CrossRefPubMedGoogle Scholar
  27. 27.
    Solomon R (2008) Contrast-induced acute kidney injury: is there a risk after intravenous contrast? Clin J Am Soc Nephrol 3:1242–1243CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Solomon R, Solomon R, Dauerman HL (2011) Contrast–induced acute kidney injury. Circulation 122:2451–2455CrossRefGoogle Scholar
  29. 29.
    Meinel FG, De Cecco CN, Schoepf UJ et al (2014) Contrast–induced acute kidney injury: definition, epidemiology, and outcome. Biomed Res Int 859328Google Scholar
  30. 30.
    Murakami R, Hayashi H, Sugizaki K et al (2012) Contrast–induced nephropathy in patients with renal insufficiency undergoing contrast–enhanced MDCT. Eur Radiol 22:2147–2152CrossRefPubMedGoogle Scholar
  31. 31.
    Bruce RJ, Djamali A, Shinki K et al (2009) Background fluctuation of kidney function versus contrast–induced nephrotoxicity. AJR Am J Roentgenol 92:711–718CrossRefGoogle Scholar
  32. 32.
    McDonald JS, McDonald RJ, Comin J et al (2013) Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis. Radiology 267:119–128CrossRefPubMedGoogle Scholar
  33. 33.
    Newhouse JH, Kho D, Rao QA et al (2008) Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol 191:376–382CrossRefPubMedGoogle Scholar
  34. 34.
    Moos SI, van Vemde DN, Stoker J et al (2013) Contrast induced nephropathy in patients undergoing intravenous (IV) contrast enhanced computed tomography (CECT) and the relationship with risk factors: a meta-analysis. Eur J Radiol 82:e387–e399CrossRefPubMedGoogle Scholar
  35. 35.
    Moos SI, Stoker J, Nagan G et al (2014) Prediction of presence of kidney disease in a general patient population undergoing intravenous iodinated contrast enhanced computed tomography. Eur Radiol 24:1266–1275PubMedGoogle Scholar
  36. 36.
    Herts BR, Schneider E, Poggio ED et al (2008) Identifying outpatients with renal insufficiency before contrast-enhanced CT by using estimated glomerular filtration rates versus serum creatinine levels. Radiology 248:106–113CrossRefPubMedGoogle Scholar
  37. 37.
    Cicin I, Erdogan B, Gulsen E et al (2014) Incidence of contrast-induced nephropathy in hospitalised patients with cancer. Eur Radiol 24:184–190CrossRefPubMedGoogle Scholar
  38. 38.
    Shin DH, Choi DJ, Youn TJ et al (2011) Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography. Am J Cardiol 108:189–194CrossRefPubMedGoogle Scholar
  39. 39.
    Prasad V, Gandhi D, Stokum C et al (2014) Incidence of contrast material–induced nephropathy after neuroendovascular procedures. Radiology 273:853–858CrossRefPubMedGoogle Scholar
  40. 40.
    Weisbord SD, Mor MK, Resnick A et al (2008) Incidence and outcomes of contrast-induced AKI following computed tomography. Clin J Am Soc Nephrol 3:1274–1281CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Rudnick M, Feldman H (2008) Contrast-induced nephropathy: what are the true clinical consequences? Clin J Am Soc Nephrol 3:263–272CrossRefPubMedGoogle Scholar
  42. 42.
    Seabra VF, Balk EM, Liangos O et al (2008) Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis. Am J Kidney Dis 52:272–284CrossRefPubMedGoogle Scholar
  43. 43.
    Iyem H, Tavli M, Akcicek F et al (2009) Importance of early dialysis for acute renal failure after an open-heart surgery. Hemodial Int 13:55–61CrossRefPubMedGoogle Scholar
  44. 44.
    Schefold JC, von Haehling S, Pschowski R et al (2014) A The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (CONVINT): a prospective randomized controlled trial. Crit Care 18:R11CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Liu YH, Liu Y, Tan N et al (2015) Contrast-induced nephropathy following chronic total occlusion percutaneous coronary intervention in patients with chronic kidney disease. Eur Radiol 25:2274–2281CrossRefPubMedGoogle Scholar
  46. 46.
    Kooiman J, Sijpkens YW, de Vries JP et al (2014) A randomized comparison of 1-h sodium bicarbonate hydration versus standard peri-procedural saline hydration in patients with chronic kidney disease undergoing intravenous contrast-enhanced computerized tomography. Nephrol Dial Transplant 29:1029–1036CrossRefPubMedGoogle Scholar
  47. 47.
    Weisbord SD, Palevsky PM (2008) Prevention of contrast-induced nephropathy with volume expansion. Clin J Am Soc Nephrol 3:273–280CrossRefPubMedGoogle Scholar
  48. 48.
    Jang JS, Jin HY, Seo JS et al (2012) Sodium bicarbonate therapy for the prevention of contrast-induced acute kidney injury – a systematic review and meta-analysis. Circ J 76:2255–2265CrossRefPubMedGoogle Scholar
  49. 49.
    Balemans CE, Reichert LJ, van Schelven BI et al (2012) Epidemiology of contrast material-induced nephropathy in the era of hydration. Radiology 263:706–713CrossRefPubMedGoogle Scholar
  50. 50.
    Nijssen EC, Vermeeren MA, Janssen MM et al (2012) Contrast material-induced nephropathy in the era of hydration. Radiology 265:978–979CrossRefPubMedGoogle Scholar
  51. 51.
    Kama A, Yılmaz S, Yaka E et al (2014) Comparison of short-term infusion regimens of N-acetylcysteine plus intravenous fluids, sodium bicarbonate plus intravenous fluids, and intravenous fluids alone for prevention of contrast-induced nephropathy in the emergency department. Acad Emerg Med 21:615–622CrossRefPubMedGoogle Scholar
  52. 52.
    Hiremath S, Akbari A, Shabana W et al (2013) Prevention of contrast-induced acute kidney injury: is simple oral hydration similar to intravenous? A systematic review of the evidence. PLoS One 8:e60009CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Traub SJ, Mitchell AM, Jones AE et al (2013) N-acetylcysteine plus intravenous fluids versus intravenous fluids alone to prevent contrast-induced nephropathy in emergency computed tomography. Ann Emerg Med 62:511–520CrossRefPubMedGoogle Scholar
  54. 54.
    Sadat U, Usman A, Gillard JH et al (2013) Does ascorbic acid protect against contrast-induced acute kidney injury in patients undergoing coronary angiography: a systematic review with meta-analysis of randomized, controlled trials. J Am Coll Cardiol 62:2167–2175CrossRefPubMedGoogle Scholar
  55. 55.
    Spatz C, Saadulla L, Lapsiwala A et al (2012) Effect of renin-angiotensin-aldosterone system blockade therapy on incidence of contrast-induced nephropathy in patients with chronic kidney disease. Iran J Kidney Dis 6:432–436PubMedPubMedCentralGoogle Scholar
  56. 56.
    Marenzi G, Ferrari C, Marana I et al (2012) Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial. JACC Cardiovasc Interv 5:90–97CrossRefPubMedGoogle Scholar
  57. 57.
    Wu MY, Hsiang HF, Wong CS et al (2013) The effectiveness of N-Acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: a meta-analysis of randomized controlled trials. Int Urol Nephrol 45:1309–1318CrossRefPubMedGoogle Scholar
  58. 58.
    Hsu TF, Huang MK, Yu SH et al (2012) N-acetylcysteine for the prevention of contrast-induced nephropathy in the emergency department. Intern Med 51:2709–2714CrossRefPubMedGoogle Scholar
  59. 59.
    Poletti PA, Platon A, De Seigneux S et al (2013) N-acetylcysteine does not prevent contrast nephropathy in patients with renal impairment undergoing emergency CT: a randomized study. BMC Nephrol 14:119CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Richenberg J (2012) How to reduce nephropathy following contrast-enhanced CT: a lesson in policy implementation. Clin Radiol 67:1136–1145CrossRefPubMedGoogle Scholar
  61. 61.
    Lu GM, Luo S, Meinel FG et al (2014) High-pitch computed tomography pulmonary angiography with iterative reconstruction at 80 kVp and 20 mL contrast agent volume. Eur Radiol 24:3260–3268CrossRefPubMedGoogle Scholar
  62. 62.
    Luo S, Zhang LJ, Meinel FG et al (2014) Low tube voltage and low contrast material volume cerebral CT angiography. Eur Radiol 24:1677–1685CrossRefPubMedGoogle Scholar
  63. 63.
    Zhang LJ, Qi L, Wang J, Tang CX et al (2014) Feasibility of prospectively ECG-triggered high-pitch coronary CT angiography with 30 mL iodinated contrast agent at 70 kVp: initial experience. Eur Radiol 24:1537–1546CrossRefPubMedGoogle Scholar
  64. 64.
    Geyer LL, Schoepf UJ, Meinel FG et al (2015) State of the Art: Iterative CT reconstruction techniques. Radiology 276:339–357CrossRefPubMedGoogle Scholar

Copyright information

© European Society of Radiology 2015

Authors and Affiliations

  • Shu Min Tao
    • 1
  • Julian L. Wichmann
    • 2
    • 3
  • U. Joseph Schoepf
    • 2
  • Stephen R. Fuller
    • 2
  • Guang Ming Lu
    • 1
  • Long Jiang Zhang
    • 1
    Email author
  1. 1.Department of Medical Imaging, Jinling HospitalMedical School of Nanjing UniversityNanjingChina
  2. 2.Division of Cardiovascular ImagingMedical University of South CarolinaCharlestonUSA
  3. 3.Department of Diagnostic and Interventional RadiologyUniversity Hospital FrankfurtFrankfurtGermany

Personalised recommendations